Solid state characterization and crystal structure from x-ray powder diffraction of two polymorphic forms of ranitidine base

Journal of Pharmaceutical Sciences

Volumn 98, Issue 1, 2009, Pages 146-158

  De Armas, Héctor Novoa ^a,b   Peeters, Oswald M ^b   Blaton, Norbert ^b   Van Gyseghem, Elke ^b   Martens, Johan ^c   Van Haele, Gerrit ^d   Van Den Mooter, Guy ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d NONE   (Belgium)

Author keywords

13C CPMAS NMR; Calorimetry; Characterization; Crystal structure; Crystallography; FTIR ATR; Polymorphism; Ranitidine base; Ranitidine hydroehloride; X ray powder diffractometry

Indexed keywords

CARBON 13; ENAMINE; NITRO DERIVATIVE; RANITIDINE;

ARTICLE; CROSS POLARIZATION WITH MAGIC ANGLE SPINNING; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STRUCTURE; HEATING; HYDROGEN BOND; INFRARED SPECTROSCOPY; MICROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLID STATE; TECHNIQUE; THERMAL ANALYSIS; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

EID: 58149239875     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21395     Document Type: Article

References (28)

1. Martindale W. 1996. The Extra Pharmacopoeia, 31st edition; Reynolds JEF, editor. London: The Pharmaceutical Press.
2. Dumanovic D, Juranic I, Dzeletovic D, Vasic VM, Jovanovic J. 1997. Protolytic constants of nizati-dine, ranitidine and N,N'-dimethyl-2-nitro-1, 1-ethenediamine, spectrophotometric and theoretical investigation. J Pharm Biomed Anal 15:1667-1678.
3. Cholerton TJ, Hunt JH, Klinkert G, Smith MM. 1984. Spectroscopic studies on ranitidine: Its structure and the influence of temperature and pH. J Chem Soc Perkin Trans 2:1761-1766.
4. Madan T. 1994. Preparation and characterization of ranitidine-HCl crystals. Drug Dev Ind Pharm 20: 1571-1588.
5. Price BJ, Clitherow JW, Bradshaw J. 1978. Aminoalkyl furan derivatives. US patent 4,128,658.
6. Crookes DJ. 1985. Aminoalkyl furan derivatives. US patent 4,521,431.
7. Khanna JM, Kumar N, Khera B, Khanna M. 1997. Process for the manufacture of form 1 ranitidine hydrochloride. US patent 5,621,120.
8. Murthy K, Radatus BK, Sidhu KPS. 1995. reissued 2002. Process for production of an improved form of form 1 ranitidine hydrochloride having improved filtration and drying characteristics. Canadian patent 2120874.
9. Ngooi TK, McGolrick JD, Antczak C, Tindall JLA. 1994. Preparation of form 1 ranitidine hydrochloride. US patent 5,338,871.
10. Ngooi TK, Antczak C, Tindall JLA, McGolrick JD. 1998. Preparation of form 1 ranitidine hydrochlor-ide. Canadian patent 2099530.
11. Sehickaneder H., Nikolopoulos A, 1997. Process for preparing form 1 ranitidine hydroehloride. US patent 5,663,381.
12. Mirmehrabi M, Rohani S, Murthy KSK, Radatus B. 2004. Characterization of tautomeric forms of ranitidine hydrochloride: Thermal analysis, solid-state NMR, X-ray. J Cryst Growth 260:517-526.
13. Hempel A, Camerman N, Mastropalo D, Camerman A. 2000. Ranitidine hydrochloride, a polymorphic crystal form. Acta Crystallogr C56:1048-1049.
14. Ishida T, In Y, Inoue M. 1990. Structure of ranitidine hydrochloride. Acta Crystallogr C46:1893-1896.
15. Huq A., Stephens PW. 2003. Subtleties in crystal structure solution from powder diffraction data using simulated annealing: Ranitidine hydrochloride. J Pharm Sci 92:244-249.
16. David WIF, Shankland K, Shankland N. 1998. Routine determination of molecular crystal structures from powder diffraction data. Chem Commun (Cambridge) 8:931-932.
17. Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK. 2000. The structure of malaria pigment, β-haematin. Nature (London) 404:307-310.
18. Florence AJ, Shankland N, Shankland K, David WIF, Pidcock E, Xu X, Johnston A, Kemmedy AR, Cox PJ, Evans JSO, Steele G, Cosgrove SD, Framp-ton CS. 2005. Solving molecular crystal structures from laboratory X-ray powder diffraction data with DASH: The state of the art and challenges. J Appl Crystallogr 38:249-259.
19. David WIF, Shankland K, Cole J, Maginn S, Motherwell WDS, Taylo R. 2001. DASH user manual. Cambridge, UK: Cambridge Crystallographic Data Centre.
20. Young RA. 1993. The Rietveld method. Oxford (UK): Oxford University Press.
21. Universal Analysis, TA Instruments software. TA Instruments, Inc. New Castle, Delaware (USA).
22. Rodríguez-Carvajal J. 2005. FullProf, version 3.20, LLB. France: CEA/Saclay.
23. Boultif A., Louër D. 1991. Indexing of powder diffraction patterns for low-symmetry lattices by the successive dichotomy method. J Appl Crystallogr 24:987-993.
24. Boultif A. Louër D. 2004. Powder pattern indexing with the dichotomy method. J Appl Crystallogr 37:724-731.
25. Allen FH. 2002. The Cambridge Structural Database: A quarter of a million crystal structures and rising. Acta Crystallogr B58:380-388.
26. 2-receptor antagonist, 2-(2-{[5-(dimethylammoniomethyl)-2-furyl]methylthio} ethylamino)-2-methylamino- l-nitroethylene hydrogen oxalate (ranitidine hydrogen oxalate). Acta Crystallogr C46:1837-1840.
27. Steiner T. 1998. Donor and acceptor strengths in CH-0 hydrogen bonds quantified from crystallographic data of small solvent molecules. N J Chem 22:1099-1103.
28. Desiraju GR. 2005. C-HO and other weak hydrogen bonds. From crystal engineering to virtual screening. Ace Chem Res 2995-3001.